Alpha-9 Theranostics

Focused on advancing a portfolio of novel radiotherapeutics and diagnostics

Alpha-9 Theranostics is a clinical-stage company developing a portfolio of radiolabeled imaging and therapeutic molecules for solid and hematologic malignancies. These differentiated molecules have the potential to meaningfully extend patients’ lives with favorable safety profiles. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of using targeted radiation to improve the lives of patients affected by cancers.

Year of Investment
Life Sciences
Vancouver, British Columbia, Canada